[go: up one dir, main page]

GB9926805D0 - Diagnostic methods - Google Patents

Diagnostic methods

Info

Publication number
GB9926805D0
GB9926805D0 GBGB9926805.4A GB9926805A GB9926805D0 GB 9926805 D0 GB9926805 D0 GB 9926805D0 GB 9926805 A GB9926805 A GB 9926805A GB 9926805 D0 GB9926805 D0 GB 9926805D0
Authority
GB
United Kingdom
Prior art keywords
diagnostic methods
diagnostic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9926805.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9926805.4A priority Critical patent/GB9926805D0/en
Publication of GB9926805D0 publication Critical patent/GB9926805D0/en
Priority to AU11631/01A priority patent/AU1163101A/en
Priority to PCT/GB2000/004267 priority patent/WO2001036674A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB9926805.4A 1999-11-13 1999-11-13 Diagnostic methods Ceased GB9926805D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9926805.4A GB9926805D0 (en) 1999-11-13 1999-11-13 Diagnostic methods
AU11631/01A AU1163101A (en) 1999-11-13 2000-11-08 Diagnostic methods
PCT/GB2000/004267 WO2001036674A2 (en) 1999-11-13 2000-11-08 Diagnostic methods for detection of prostate disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9926805.4A GB9926805D0 (en) 1999-11-13 1999-11-13 Diagnostic methods

Publications (1)

Publication Number Publication Date
GB9926805D0 true GB9926805D0 (en) 2000-01-12

Family

ID=10864423

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9926805.4A Ceased GB9926805D0 (en) 1999-11-13 1999-11-13 Diagnostic methods

Country Status (3)

Country Link
AU (1) AU1163101A (en)
GB (1) GB9926805D0 (en)
WO (1) WO2001036674A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2402729A1 (en) * 2000-03-15 2001-09-20 Incyte Genomics, Inc. Human immune response proteins
AU2001266790A1 (en) * 2000-06-09 2001-12-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US6939670B2 (en) * 2001-03-12 2005-09-06 Monogen, Inc. Cell-based detection and differentiation of lung cancer
US6537811B1 (en) 2001-08-01 2003-03-25 Isis Pharmaceuticals, Inc. Antisense inhibition of SAP-1 expression
AU2002365538A1 (en) * 2001-11-27 2003-06-10 Nexyte Ab Production of eukaryotic proteins and nucleic acid molecules in c. elegans
US20030148394A1 (en) * 2002-01-18 2003-08-07 Millennium Pharmaceuticals, Inc. Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058, or 6351 molecules
US20050037447A1 (en) * 2003-07-08 2005-02-17 Yong-Chuan Wong Protein markers for human benign prostatic hyperplasia (BPH)
AU2011282892B2 (en) 2010-07-27 2015-07-16 Mdxhealth Sa Method for using gene expression to determine prognosis of prostate cancer
CN112592974A (en) * 2019-12-13 2021-04-02 四川省人民医院 Diagnostic agent, kit and use for diagnosing or aiding in the diagnosis of renal insufficiency or renal injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease

Also Published As

Publication number Publication date
AU1163101A (en) 2001-05-30
WO2001036674A3 (en) 2002-03-28
WO2001036674A2 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
GB9910938D0 (en) Diagnostic apparatus
GB0013515D0 (en) Endoscope
TW501425U (en) Slider-pull-assembling unit
GB0004232D0 (en) Diagnostic method
GB9926161D0 (en) Methods
GB9905817D0 (en) Methods
GB9926805D0 (en) Diagnostic methods
GB2364577B (en) Diagnostic system
GB0026604D0 (en) Diagnostic method
EP1170018A4 (en) Ligand-bonded complex
GB0029270D0 (en) Diagnostic method
GB9929720D0 (en) Diagnostic method
GB0126074D0 (en) Tomographic system
GB9920336D0 (en) Retinoscope
GB9924717D0 (en) Diagnostic
GB0002366D0 (en) Diagnostic method
GB9921708D0 (en) Diagnostic method
GB9920277D0 (en) Diagnostic method
GB9916669D0 (en) Diagnostic method
GB9924534D0 (en) Diagnostic Method
GB9926293D0 (en) Diagnostic method
GB9914943D0 (en) Methods
GB9908525D0 (en) Methods
TW387258U (en) Medical air-sucker
GB0016169D0 (en) Diagnostic method

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)